New drug shows promise for controlling debilitating Crohn's symptoms
NCT ID NCT04397263
Summary
This study tested the safety and effectiveness of guselkumab, an injectable medication, in adults with moderate to severe Crohn's disease. The 38 participants had active symptoms and had not responded well to previous treatments. Researchers monitored side effects and whether the drug reduced disease activity and improved symptoms over 48 weeks.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CROHNS DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Asahikawa Medical University Hospital
Hokkaido, 078 8510, Japan
-
Hitachi General Hospital
Hitachi, 317-0077, Japan
-
Hyogo Medical University Hospital
Nishinomiya Shi, 663 8501, Japan
-
Institute of Science Tokyo Hospital
Bunkyō City, 113 8519, Japan
-
Ishida Clinic of IBD and Gastroenterology
Ōita, 870 0823, Japan
-
Japanese Red Cross Kumamoto Hospital
Kumamoto, 861-8520, Japan
-
Jichi Medical University Hospital
Shimotsuke, 329-0498, Japan
-
KOKIKAI Tokatsu Tsujinaka Hospital
Abiko, 270-1168, Japan
-
Kenseikai Dongo Hospital
Nara, 635-0022, Japan
-
Kishiwada Tokushukai Hospital
Kishiwada, 5960042, Japan
-
Kitasato University Hospital
Sagamihara, 252-0375, Japan
-
Kumamoto University Hospital
Kumamoto, 860-8556, Japan
-
Kyorin University Hospital
Mitaka, 181-8611, Japan
-
National Center for Global Health and Medicine
Shinjuku- Ku, 162-8655, Japan
-
National Hospital Organization Toyohashi Medical Center
Toyohashi, 441-8570, Japan
-
Ofuna Chuo Hospital
Kamakura, 247-0056, Japan
-
Okayama University Hospital
Okayama, 700-8558, Japan
-
Osaka Medical and Pharmaceutical University Hospital
Takatsuki, 569-8686, Japan
-
Saga University Hospital
Saga, 849-8501, Japan
-
Saitama Medical Center
Saitama, 350 8550, Japan
-
Sapporo Tokushukai Hospital
Sapporo, 004-0041, Japan
-
Sendai Kosei Hospital
Sendai Miyagi, 9810914, Japan
-
Tokyo Metropolitan Bokutoh Hospital
Sumida Ku, 130 8575, Japan
-
Tokyo Women's Medical University Hospital
Shinjuku-ku, 162-8666, Japan
-
Toyama Prefectural Central Hospital
Toyama, 9308550, Japan
Conditions
Explore the condition pages connected to this study.